RecruitingNCT06850818

Heidelberg Registry for Hip and Knee Joint Implants and Revisions

Endoprosthesis Registry Heidelberg (EPR-HD): Registry for the Analysis of Patients Following Primary Implantation or Revision Surgery of Artificial Joints in Hip and Knee Joint Pathologies


Sponsor

University Hospital Heidelberg

Enrollment

10,000 participants

Start Date

Jan 1, 2007

Study Type

OBSERVATIONAL

Conditions

Summary

The Endoprosthesis Registry Heidelberg (EPR-HD) is a clinical registry designed to systematically collect and analyze data from patients undergoing primary implantation or revision surgery of artificial hip and knee joints. The main objective of the registry is to evaluate long-term outcomes, complication rates, implant survival, and functional results associated with joint replacement procedures in patients with various hip and knee joint pathologies. By gathering comprehensive clinical data, EPR-HD aims to improve the understanding of patient outcomes after endoprosthetic procedures, identify potential factors influencing implant success, and support evidence-based improvements in surgical techniques and patient care. The registry includes adult patients treated at Heidelberg University Hospital, with data collected at multiple time points during routine clinical follow-up. This registry will contribute to the optimization of joint replacement strategies and promote high-quality patient care.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • All patients undergoing hip or knee arthroplasty at our institution
  • All patients undergoing revision surgery following hip oder knee arthroplasty

Exclusion Criteria3

  • Lack of prospective consent for study participation
  • Lack of capacity to provide informed consent
  • Minor status (underage)

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Hospital Heidelberg

Heidelberg, Baden-Wurttemberg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06850818


Related Trials